Spectrum Pharmaceuticals
Henderson, US · Founded 2002 · Delaware corporation · 144 employees on LinkedIn
Find your way into Spectrum Pharmaceuticals
Sign up to see every warm intro you have to Spectrum Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spectrum Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RC
Rajesh C. ShrotriyaExecutive
KA

Kurt A. GustafsonChief Financial Officer2013–2022Kurt Gustafson spent 15 years at Amgen in progressively senior financial roles, including Treasurer and CFO of International Operations, before joining Halozyme Therapeutics as CFO in 2009. He subsequently held the CFO position at Spectrum Pharmaceuticals starting in 2013 and later at OmniAb, and holds degrees in Accounting from North Park University and an MBA from UCLA.
JT

Joseph TurgeonSenior Compliance Manager2019–2022Joseph Turgeon has spent over 10 years in specialty pharmaceutical sales and market access roles focused on oncology, working with healthcare providers to support patient access to therapies in the buy-and-bill market. He has held positions spanning clinical operations, reimbursement strategy, and account management across community and academic settings.
Board
AE
Anthony E. MaidaBoard director
GR
Gilles R. GagnonBoard director
SM
Stuart M. KrasnerBoard director
LL
Luigi LenazBoard director
RW

DV
Dolatrai VyasBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2016
▶$3MraisedApr 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$3MraisedApr 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anthony E. MaidaDirector
- Gilles R. GagnonDirector
- Stuart M. KrasnerDirector
- Luigi LenazDirector
- Rajesh C. ShrotriyaExecutive Officer, Director
- Raymond W. CohenDirector
- Kurt A. GustafsonExecutive Officer
- Joseph TurgeonExecutive Officer
- Dolatrai VyasDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Spectrum Pharmaceuticals raised?
- Spectrum Pharmaceuticals has disclosed $3M raised across 1 round.
- Where is Spectrum Pharmaceuticals headquartered?
- Spectrum Pharmaceuticals is headquartered in Henderson, US.